Abecma Or Bust: 2seventy Sells Final Research Program To Novo

 
• By Jessica Merrill
  
hemophilia
2Seventy sold rights to a hemophilia A program to Novo Nordisk • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business